Cyclerion Therapeutics Inc (CYCN) — Financial Flexibility Index
Cyclerion Therapeutics Inc (CYCN) has a Financial Flexibility Index of -1.75x as of December 2025. Free cash flow of $-1.58 Million (operating CF $-1.58 Million minus capex $0.00) represents -2% of total liabilities ($900.00K). Also explore CYCN shareholders equity momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Cyclerion Therapeutics Inc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Cyclerion Therapeutics Inc across 10 annual periods. Check strategic asset allocation of Cyclerion Therapeutics Inc to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Cyclerion Therapeutics Inc (2016–2025)
Year-by-year free cash flow to debt coverage for Cyclerion Therapeutics Inc. For the full company profile including market capitalisation, see CYCN stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.68x | $-3.31 Million | $-3.31 Million | $900.00K | ▲ +38.4% |
| 2024 | -5.98x | $-4.33 Million | $-4.33 Million | $725.00K | ▲ +41.3% |
| 2023 | -10.18x | $-21.25 Million | $-21.25 Million | $2.09 Million | ▼ -91.3% |
| 2022 | -5.32x | $-40.61 Million | $-40.61 Million | $7.63 Million | ▼ -61.7% |
| 2021 | -3.29x | $-36.51 Million | $-36.52 Million | $11.09 Million | ▼ -159.4% |
| 2020 | -1.27x | $-70.97 Million | $-72.49 Million | $55.88 Million | ▼ -18.2% |
| 2019 | -1.07x | $-95.33 Million | $-102.22 Million | $88.75 Million | ▲ +79.6% |
| 2018 | -5.27x | $-94.06 Million | $-97.50 Million | $17.85 Million | ▲ +7.3% |
| 2017 | -5.69x | $-79.81 Million | $-81.22 Million | $14.04 Million | ▼ -24.9% |
| 2016 | -4.55x | $-48.43 Million | $-49.87 Million | $10.64 Million | — |